Therapy of the status of symptom clusters in patients with cancer receiving FOLFOX6 chemotherapy
10.3760/cma.j.issn.1672-7088.2019.21.003
- VernacularTitle: FOLFOX6方案癌症患者化疗不同时期症状群分析
- Author:
Xing ZHENG
1
;
Aijun WANG
Author Information
1. Department of Chemotherapy, Qilu Hospital of Shandong University, Ji′nan 250012, China
- Publication Type:Journal Article
- Keywords:
Neoplasm;
Chemotherapy;
Symptoms clusters;
Continuing nursing
- From:
Chinese Journal of Practical Nursing
2019;35(21):1613-1617
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To invest the status of symptom clusters in patients with cancer receiving FOLFOX6 chemotherapy during the course of chemotherapy.
Methods:Total 100 patients with cancer receiving FOLFOX6 chemotherapy were investigated using MD. Anderson Symptom Inventory-Chinese (MDASI-C).
Results:The top severity of symptoms were lack of appetite and nausea during chemotherapy; weary was the highest score during the intermission of chemotherapy. Exploratory factor analysis showed four main symptom clusters: gastrointestinal symptom clusters, physical symptom clusters, mental symptom clusters and subjective feeling clusters. There were no significant difference in the scores of subjective feeling clusters between chemotherapy and the first day after discharge (P>0.05), other symptom clusters also declined slowly; the symptom clusters began to ease significantly from the three day after discharge (P<0.05).
Conclusion:Patients with cancer suffer from multiple symptoms during FOLFOX6 chemotherapy and during the intermission of chemotherapy. The results are good for establishing early predictions of symptom clusters in intermission of chemotherapy.
